Literature DB >> 4834550

Simplified cholangiography using ioglycamide.

G J Parkin, H Herlinger.   

Abstract

Intravenous cholangiograms were performed on 100 unselected nonicteric patients using methylglucamine ioglycamide (Biligram). Fifty patients received 10.5 g of contrast medium and 50 received 5.25 g of medium. The contrast medium was injected evenly over five minutes. Side effects were recorded in only 13% of patients and all were mild. Radiographs were taken 10, 30, 60, 90, and 120 minutes after injection and were assessed without the authors being aware of the dose of contrast medium injected.Better statistically significant results were obtained using the higher dose.In patients in whom the gallbladder is present, films taken at 60 minutes and 90 minutes after injection give the maximum available information in 97% of cases. If the gallbladder has not become opacified by 60 minutes, cystic duct obstruction is indicated. In postcholecystectomy patients, films at 30 minutes and 60 minutes after injection give the maximum available information in 95% of cases.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4834550      PMCID: PMC1412960          DOI: 10.1136/gut.15.4.268

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  4 in total

1.  [THE POSITIVE CHOLANGIOGRAM AS A CRITERION FOR THE STANDARD FOR BILIARY CONTRAST MEDIA. (IMPROVED BILE DUCT DIAGNOSIS WITH BILIVISTAN)].

Authors:  G HOPPE
Journal:  Fortschr Geb Rontgenstr Nuklearmed       Date:  1964-04

2.  [Clinical testing of an improved contrast media for intravenous cholangiocystography].

Authors:  H Braband; J Ciarkowski
Journal:  Rontgenpraxis       Date:  1970-04

3.  Intravenous cholangiography. An experimental evaluation of several currently proposed methods.

Authors:  A A Moss; J Nelson; J Amberg
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1973-02

4.  Bilivistan--a new contrast medium for intravenous cholangiocystography. Preliminary report.

Authors:  H D Bell; H Braband
Journal:  Br J Radiol       Date:  1966-01       Impact factor: 3.039

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.